Study finds bone density loss associated with levothyroxine

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

The Future of Human Health May Require Unlocking Access to Our Health Data

Cambron Carter, Co-founder and Chief Technology Officer at Pearl The synergy of artificial intelligence (AI) and medical imaging has opened new horizons for healthcare. AI-mediated

April 23, 2024

AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi – Pharmaceutical Technology

Both Tagrisso and Imfinzi have been recommended by England’s NICE to treat patients with lung cancer in England and Wales. Credit: Roland Magnusson via Getty

January 22, 2025

Trying to time your seasonal vaccines just right? There are no easy answers, but here are some factors to consider

With fall coming into view, public health officials across the country are turning to the annual task of persuading legions of Americans to get vaccinated

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.